NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,704.00
+3.00 (0.18%)
At close: Dec 5, 2025

NGeneBio Revenue

NGeneBio had revenue of 5.43B KRW in the quarter ending September 30, 2025, with 162.06% growth. This brings the company's revenue in the last twelve months to 9.98B, up 61.66% year-over-year. In the year 2024, NGeneBio had annual revenue of 5.69B with 30.80% growth.

Revenue (ttm)
9.98B
Revenue Growth
+61.66%
P/S Ratio
4.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
42.66B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20245.69B1.34B30.80%
Dec 31, 20234.35B-6.67B-60.51%
Dec 31, 202211.02B3.85B53.81%
Dec 31, 20217.16B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition